Antonella Aiello
Overview
Explore the profile of Antonella Aiello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barone A, Chiappella A, Casadei B, Bramanti S, Ljevar S, Chiusolo P, et al.
Br J Haematol
. 2024 Jun;
205(4):1356-1360.
PMID: 38877876
Secondary primary malignancies (SPM) have been reported after anti-BCMA or anti-CD19 chimeric antigen receptor (CAR)-T-cell therapies. While the cytotoxic effect of antecedent therapies, including chemotherapy and radiotherapy, has been well...
2.
Sala L, Ciniselli C, Bozzi F, Summo V, Bonini C, Brich S, et al.
Tumori
. 2023 Aug;
110(1):49-59.
PMID: 37574933
Introduction: The synthesis of the periprosthetic capsule during implant-based breast reconstruction is the result of a coordinate cascade of inflammatory events ending in a fibrous tissue deposition around the expander...
3.
Vittoria L, Sala L, Summo V, Capone I, Conca E, Toma M, et al.
Tumori
. 2023 Mar;
109(5):458-465.
PMID: 36942354
Introduction: During the last few years it has been shown that an anaplastic T cell lymphoma can develop as a rare and late sequelae of implant-based breast reconstruction. This malignancy...
4.
DArena G, Sgambato A, Volpe S, Coppola G, Amodeo R, Tirino V, et al.
Hematol Oncol
. 2022 Jun;
40(5):835-842.
PMID: 35667043
Measurable residual disease (MRD) has emerged as a relevant parameter of response to therapy in chronic lymphocytic leukemia (CLL). Although several methods have been developed, flow cytometry has emerged as...
5.
Minna E, Romeo P, Dugo M, De Cecco L, Aiello A, Pistore F, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454858
Medullary thyroid carcinoma (MTC) is a rare but aggressive tumor. Although and genes are recognized drivers in MTC, associated downstream signaling pathways are largely unknown. In this study, we report...
6.
DArena G, Volpe S, Amodeo R, Tirino V, DAuria F, Annamaria G, et al.
Int J Lab Hematol
. 2021 Nov;
44(3):e120-e122.
PMID: 34796668
No abstract available.
7.
Vittoria L, Bozzi F, Capone I, Carniti C, Lorenzini D, Gobbo M, et al.
Cytometry B Clin Cytom
. 2020 Dec;
100(6):692-694.
PMID: 33337573
No abstract available.
8.
Romeo P, Colombo C, Granata R, Calareso G, Gualeni A, Dugo M, et al.
Endocr Relat Cancer
. 2018 Jan;
25(3):217-231.
PMID: 29298817
This study aimed to identify circulating miRNAs as novel non-invasive biomarkers for prognosis and vandetanib response in advanced medullary thyroid cancer (MTC) patients. We prospectively recruited two independent cohorts of...
9.
Di Bernardo A, Mussetti A, Aiello A, De Paoli E, Cabras A
Am J Clin Pathol
. 2014 Jul;
142(2):227-32.
PMID: 25015865
Objectives: Richter transformation (RT) represents the rare occurrence of a secondary aggressive lymphoma in the setting of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Methods: Here we describe the peculiar case...
10.
Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali P, et al.
Histopathology
. 2014 Jun;
64(7):1014-26.
PMID: 24898918
Aims: Primary Ewing sarcoma of the ileum has rarely been documented. Little is known about its pathogenesis and clinical implications, and it would be helpful to identify novel molecular markers....